Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-11939378-B2 · Mar 26, 2024 · US
This page is not indexed by search engines while we improve data quality.
Kwon Eugene D patents
Kwon Eugene D is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kwon Eugene D |
| Total patents | 26 |
| First publication | Feb 12, 2015 |
| Latest publication | Mar 26, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-11242387-B2 · Feb 8, 2022 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2021380690-A1 · Dec 9, 2021 · US
Methods for treating cancer in patients with elevated levels of Bim
US-11136393-B2 · Oct 5, 2021 · US
Soluble B7-H1
US-2020326344-A1 · Oct 15, 2020 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2020002419-A1 · Jan 2, 2020 · US
Methods for treating cancer in patients with elevated levels of bim
US-2019315869-A1 · Oct 17, 2019 · US
Methods for treating cancer in patients with elevated levels of BIM
US-10259875-B2 · Apr 16, 2019 · US
Methods and materials for treating cancer
US-10167336-B2 · Jan 1, 2019 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2018179281-A1 · Jun 28, 2018 · US
Recent patents
Latest publications not already listed above.
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2018100015-A1 · Apr 12, 2018 · US
Soluble B7-H1
US-2017363634-A1 · Dec 21, 2017 · US
Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-9803015-B2 · Oct 31, 2017 · US
B7-h3 in cancer
US-2017146539-A1 · May 25, 2017 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2016264667-A1 · Sep 15, 2016 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2016257953-A1 · Sep 8, 2016 · US
Methods for treating cancer in patients with elevated levels of bim
US-2016251437-A1 · Sep 1, 2016 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2016245816-A1 · Aug 25, 2016 · US
Methods and materials for treating cancer
US-2016176967-A1 · Jun 23, 2016 · US
B7-h1 and b7-h4 in cancer
US-2016153996-A1 · Jun 2, 2016 · US
B7-h1 and survivin in cancer
US-2016154000-A1 · Jun 2, 2016 · US
Methods and materials for treating cancer
US-9302005-B2 · Apr 5, 2016 · US
B7-h4 expression on tumor vasculature
US-2016051675-A1 · Feb 25, 2016 · US
B7-H4 expression on tumor vasculature
US-9121853-B2 · Sep 1, 2015 · US
Soluble B7-H1
US-2015111232-A1 · Apr 23, 2015 · US
Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
US-2015044165-A1 · Feb 12, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Mayo Foundation | 14 |
| Mayo Found Medical Education & Res | 12 |
| Kwon Eugene D | 1 |
| Cheville John | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/5758 | 22 |
| C07K2317/76 | 20 |
| C07K16/2827 | 18 |
| G01N33/57525 | 17 |
| G01N33/57557 | 16 |